Franchising rabies vaccine delivery: The case of Indian immunologicals

PLoS Neglected Tropical Diseases

Volumn 5, Issue 4, 2011, Pages

  Masum, Hassan ^a   Batavia, Hima ^a   Bhogal, Natasha ^a   Le, Kim ^b   Singer, Peter A ^a  

^a McLaughlin Rotman Centre for Global Health   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE; RABIPURE; UNCLASSIFIED DRUG;

ARTICLE; DEVELOPING COUNTRY; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; GOVERNMENT; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; IMMUNIZATION; INDIA; MORTALITY; POVERTY; PUBLIC HEALTH; RABIES; WORLD HEALTH ORGANIZATION; IMMUNOLOGY; METHODOLOGY; ORGANIZATION AND MANAGEMENT; VACCINATION;

DELIVERY OF HEALTH CARE; HUMANS; INDIA; RABIES; RABIES VACCINES; VACCINATION;

EID: 79955816251     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000946     Document Type: Article

References (20)

1. World Health Organization (2008) Rabies fact sheet. N°99. Available: http://www.who.int/mediacentre/factsheets/fs099/en/. Accessed 28 March 2011.
2. Sudarshan MK, (2004) Assessing burden of rabies in India. WHO sponsored national multi-centric rabies survey. Assoc Prev Control Rabies India 6: 44-45.
3. Sudarshan MK, (2007) Assessing the burden of rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis 11: 29-35.
4. World Health Organization (2008) Rabies in the South-East Asia region. Available: http://www.searo.who.int/LinkFiles/CDS_rabies.pdf.pdf. Accessed 28 March 2011.
5. Schlein K, Kinlaw H, Montagu D, (2010) Clinical social franchising compendium: an annual survey of programs, 2010 San Francisco The Global Health Group, Global Health Sciences, University of California, San Francisco.
6. John TJ, (1997) An ethical dilemma in rabies immunisation. Vaccine 15 (Suppl): S12-S15.
7. Sudarshan MK, Mahendra BJ, Ashwath Narayana DH, (2005) Introducing intra-dermal rabies vaccination in India: rationale and action plan. Seventh National Conference on Rabies; 7-9 July 2005; Shimla, Himachal Pradesh, India.
8. Warrell MJ, (2003) The challenge to provide affordable rabies post-exposure treatment. Vaccine 21: 706-709.
9. Jayaraman KS, (1999) India fast-tracks vaccine candidates. Nat Med 5: 970.
10. Indian Immunologicals Limited (2008) 2007-2008 annual report Hyderabad Indian Immunologicals Limited.
11. Indian Immunologicals Limited (2009) 2008-2009 annual report Hyderabad Indian Immunologicals Limited.
12. Sampath G, Reddy SV, Rao ML, Rao YU, Palaniappan C, (2005) An immunogenicity study of a newly introduced purified vero cell rabies vaccine (abhayrab) manufactured in India. Vaccine 23: 897-900.
13. Samant Y, Lanjewar H, Parker D, Block L, Tomar GS, et al. (2007) Evaluation of the cold-chain for oral polio vaccine in a rural district of India. Public Health Rep 122: 112-121.
14. World Health Organization (2007) Current WHO guide for rabies pre and post-exposure prophylaxis in humans. Available: http://www.who.int/entity/rabies/PEP_prophylaxis_guidelines_June09.pdf. Accessed 28 March 2011.
15. Wunner WH, Briggs DJ, (2010) Rabies in the 21st Century. PLoS Negl Trop Dis 4: e591 doi:10.1371/journal.pntd.0000591.
16. Frost LJ, Reich MR, (2008) Access: how do good health technologies get to poor people in poor countries? Cambridge (Massachusetts) Harvard University Press.
17. Ichhpujani RL, Mala C, Veena M, Singh J, Bhardwaj M, et al. (2008) Epidemiology of animal bites and rabies cases in India: a multicentric study. J Commun Dis 40: 27-36.
18. World Health Organization Country Office for India (2008) Universal immunization program. Available: http://www.whoindia.org/EN/Section6/Section284/Section286.htm Accessed 28 March 2011.
19. Kristensen D, Chen D, (2010) Stabilization of vaccines: lessons learned. Hum Vaccin 6: 229-231.
20. Menezes R, (2008) Rabies in India. CMAJ 178: 564-566.